Hobbs Group Advisors »

Oncolytics Biotech shares owned by Hobbs Group Advisors

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Hobbs Group Advisors from 13F filings

Historical chart of Hobbs Group Advisors investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Hobbs Group Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Hobbs Group Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $142 105 1.35

More positions owned by Hobbs Group Advisors

Ea Series Trust Astoria U S Qual (ROE)
Spdr Ser Tr Portfolio Intrmd (SPIB)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Spdr Ser Tr Portfli Intrmdit (SPTI)
Investment Managers Ser Tr I Axs Astoria Infl (PPI)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Wisdomtree Tr Itl Hdg Qtly Div (IHDG)
Wisdomtree Tr Em Mkts Qtly Div (DGRE)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Agf Invts Tr Us Market Netrl (BTAL)
World Gold Tr Spdr Gld Minis (GLDM)
Bondbloxx Etf Trust Bloomberg Six Mn (XHLF)
Invesco Exch Traded Fd Tr Ii Taxable Mun Bd (BAB)
Invesco Exchange Traded Fd T S&p 500 Garp Etf (SPGP)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)

View all positions for Hobbs Group Advisors

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co
Kingsview Wealth Management

View all funds holding Oncolytics Biotech